Want to see HYEX full AI Analyst Report?
HYEX Stock Chart & Stats
$1.17
<$0.01(1.01%)
At close: 4:00 PM EDT
$1.17
<$0.01(1.01%)
Day’s Range― - ―
52-Week Range$0.81 - $3.14
Previous CloseN/A
Volume300.00
Average Volume (3M)1.29K
Market Cap
$17.25M
Enterprise Value$44.02
Total Cash (Recent Filing)$189.96K
Total Debt (Recent Filing)$9.07M
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Nov 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding14,741,348
10 Day Avg. Volume902
30 Day Avg. Volume1,290
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.59
Price to Sales (P/S)3.13
P/FCF Ratio96.73
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.13
Revenue Forecast (FY)$14.12M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue expansion indicates improving market reach and product demand. Continued growth can provide operating leverage and help Healthy Extracts spread fixed costs as the business scales.
Strong Gross EconomicsA strong gross margin gives the company room to fund marketing, product development and overhead while retaining attractive unit economics. This supports a potential path to profitability if operating expenses become more efficient.
Improving Cash GenerationThe shift from negative cash flow in 2021–2023 to positive operating and free cash flow suggests better working-capital and expense control. This improves internal funding capacity, although the current cushion remains modest.
Bears Say
Persistent Operating LossesHealthy Extracts has not yet converted revenue growth and strong gross margins into sustainable operating profits. Persistent losses can constrain reinvestment, increase reliance on external capital and weaken resilience if growth slows.
Limited Debt-Service CushionPositive cash flow is still small relative to the debt burden, leaving limited protection if costs rise or demand weakens. Increased debt versus 2025 heightens the need for continued operational improvement and disciplined liquidity management.
Leadership TurnoverLeaving two senior operating and branding positions vacant creates execution and governance risk during a period when the company needs consistent commercialization and cost discipline. Prolonged vacancies could slow strategy implementation and weaken accountability.
Healthy Extracts News
HYEX FAQ
What was Healthy Extracts’s price range in the past 12 months?
Healthy Extracts lowest stock price was $0.81 and its highest was $3.14 in the past 12 months.
What is Healthy Extracts’s market cap?
Healthy Extracts’s market cap is $17.25M.
When is Healthy Extracts’s upcoming earnings report date?
Healthy Extracts’s upcoming earnings report date is Nov 17, 2026 which is in 79 days.
How were Healthy Extracts’s earnings last quarter?
Healthy Extracts released its earnings results on Aug 14, 2026. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Healthy Extracts overvalued?
According to Wall Street analysts Healthy Extracts’s price is currently Overvalued.
Does Healthy Extracts pay dividends?
Healthy Extracts does not currently pay dividends.
What is Healthy Extracts’s EPS estimate?
Healthy Extracts’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Healthy Extracts have?
Healthy Extracts has 14,741,348 shares outstanding.
What happened to Healthy Extracts’s price movement after its last earnings report?
Healthy Extracts reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Healthy Extracts?
Currently, no hedge funds are holding shares in HYEX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Healthy Extracts
Healthy Extracts Inc., through its various divisions, specializes in the global and domestic research, development, and sale of natural botanical products. Its portfolio encompasses dietary supplements crafted for cardiovascular wellness, alongside KETONOMICS-branded neuro-enhancers aimed at boosting cognitive functions like memory, mental acuity, concentration, and neural energy. The company further supplies encapsulated bergamot products, available under distinct labels such as BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, and BergaMet SPORTSHEART. These bergamot offerings are distributed via its online platform and various other channels. Established in 2014 and based in Littleton, Colorado, the company was previously known as Grey Cloak Tech Inc. until its name change in October 2020.
Technical Analysis
Rockwell Med
―
SCYNEXIS
―
Aytu BioScience
―
Cumberland Pharmaceuticals
―
Cosmos Holdings
―
Ownership Overview
77.41% Insiders
―
Mutual Funds
― Other Institutional Investors
22.59% Public Companies and
Individual Investors